According to SPER Market Research analysis,
the global regenerative medicine market is predicted to grow at a CAGR 10.5% during the forecast period 2020-2027, owing to the rising government investments in regenerative medicine. Additionally, the spread of chronic diseases and the increasing elderly population will augment the global regenerative medicine market in the upcoming period.
According to WHO, the proportion of the burden of non-communicable diseases expected to increase to 57% by 2020. Almost half of the total chronic disease deaths are attributable to cardiovascular diseases, obesity, and diabetes. It has projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischaemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries.
Companies Covered
- Integra LifeSciences Corporation
- MiMedx Group, Inc.
- AstraZeneca
- F. Hoffmann-La Roche Ltd
- Merck & Co., Inc.
- Pfizer Inc.
- Stryker Corporation
- Other Prominent Players
Key Questions Answered by Report
- What was the market size trend of 2015-19?
- What will be the market size trend of next 4-5 years?
- What are the most common brands in terms of value?
- And others
Reasons to buy this report
- This SPER Market Research report will help to develop business strategies by understanding the trends shaping and driving global regenerative medicine market.
- Organize sales and marketing efforts by identifying the best opportunities for global regenerative medicine market.
To understand the future market competition in the global regenerative medicine market.
The report is based on in-depth qualitative and quantitative analysis of the Global Regenerative Medicine Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Browse report overview on "Global Regenerative Medicine Market by Technology (Cellular Therapy, Gene Therapy, Tissue Engineering, and Exosome Therapeutics), By Source (Autologous and Allogenic), By Application (Dermatology, Musculoskeletal, Oncology, Cardiovascular, Neurology, Hematology & Immunology, and Others), By End-Users (Hospitals, Ambulatory surgery centers (ASCs), Clinics and Others), and By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)-Global forecast from 2020-2027" at:
https://www.sperresearch.com/report-store/Regenerative-Medicine-Market.aspx